A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency
Observational Study on Vitamin C-Injektopas® 7.5g in Patients With Vitamin C Deficiency Due to Acute and Chronic Diseases
Pascoe Pharmazeutische Praeparate GmbH
1,000 participants
Jan 12, 2019
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to learn more about the disease and the symptoms where the product will use and in which patient groups. Further on, it is interesting to know clinical pictures, the symptoms improve. Patients with acute or chronical disease with vitamin c deficiency could be involved. The main questions it aims to answer are: * how do the symptoms of the disease change * how is the tolerability
Eligibility
Inclusion Criteria2
- Patients with vitamin C deficiency
- Age ≥ 18 years
Exclusion Criteria6
- Hypersensitivity to the active ingredient or any of the excipients
- Oxalate urolithiasis
- Iron storage disease (thalassemia, hemochromatosis, sideroblastic anemia) or recent red blood cell transfusion
- Renal insufficiency
- Glucose-6-phosphate dehydrogenase deficiency/defect
- Pregnant/breastfeeding women
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06983847